BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF
t: +44 (0) 115 8880 406f: +44 (0) 115 8229345

News Articles

A brave new world for supplementary protection certificates?

01 August 2012

Life Sciences Intellectual Property Review 2012
Authors: Mike Snodin and Michael Pears

This article appeared in the 2012 edition of Life Sciences Intellectual Property Review. It discusses the opinion of Advocate-General Verica Trstenjak in the case of Neurim Pharmaceuticals (C-130/11). Whilst agreeing that it would be very harsh upon Neurim if they were not awarded and SPC, Mike and Michael highlight possible undesired side-effects in implementing the particular "fix" proposed by the Advocate-General that would award an SPC to Neurim.

Cookies & Privacy

We Use Cookies To Improve User Experience. If You Continue Without Changing Settings We Will Assume You Are Happy To Receive Cookies

Disable Cookies
Privacy & Cookies | Terms & Conditions